Annual Operating Expenses
$382.01 M
+$28.95 M+8.20%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual total operating expenses is $382.01 million, with the most recent change of +$28.95 million (+8.20%) on December 31, 2023.
- During the last 3 years, RVNC annual operating expenses has risen by +$98.29 million (+34.64%).
- RVNC annual operating expenses is now at all-time high.
Performance
RVNC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$74.50 M
-$7.77 M-9.44%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly total operating expenses is $74.50 million, with the most recent change of -$7.77 million (-9.44%) on September 30, 2024.
- Over the past year, RVNC quarterly operating expenses has dropped by -$351.00 thousand (-0.47%).
- RVNC quarterly operating expenses is now -44.41% below its all-time high of $134.01 million, reached on December 31, 2023.
Performance
RVNC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RVNC Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | -0.5% |
| 3 y3 years | +34.6% | -13.9% |
| 5 y5 years | +161.0% | +74.9% |
RVNC Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.1% | -44.4% | at low |
| 5 y | 5-year | at high | +131.7% | -44.4% | +61.0% |
| alltime | all time | at high | +1250.3% | -44.4% | +784.2% |
Revance Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $74.50 M(-9.4%) |
| Jun 2024 | - | $82.27 M(-1.9%) |
| Mar 2024 | - | $83.85 M(-37.4%) |
| Dec 2023 | $382.01 M(+8.2%) | $134.01 M(+79.0%) |
| Sep 2023 | - | $74.85 M(-19.6%) |
| Jun 2023 | - | $93.15 M(+16.4%) |
| Mar 2023 | - | $80.00 M(-20.8%) |
| Dec 2022 | $353.07 M(+7.3%) | $101.03 M(+5.5%) |
| Sep 2022 | - | $95.76 M(+24.9%) |
| Jun 2022 | - | $76.69 M(-3.6%) |
| Mar 2022 | - | $79.59 M(-0.1%) |
| Dec 2021 | $329.06 M(+16.0%) | $79.67 M(-8.0%) |
| Sep 2021 | - | $86.58 M(+3.4%) |
| Jun 2021 | - | $83.72 M(+5.8%) |
| Mar 2021 | - | $79.09 M(-7.4%) |
| Dec 2020 | $283.72 M(+72.1%) | $85.44 M(+7.0%) |
| Sep 2020 | - | $79.88 M(+39.2%) |
| Jun 2020 | - | $57.38 M(-6.0%) |
| Mar 2020 | - | $61.02 M(+31.9%) |
| Dec 2019 | $164.87 M(+12.6%) | $46.26 M(+8.6%) |
| Sep 2019 | - | $42.59 M(+8.9%) |
| Jun 2019 | - | $39.12 M(+6.0%) |
| Mar 2019 | - | $36.91 M(-5.1%) |
| Dec 2018 | $146.36 M | $38.89 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $36.00 M(+1.1%) |
| Jun 2018 | - | $35.60 M(-0.7%) |
| Mar 2018 | - | $35.85 M(+9.0%) |
| Dec 2017 | $117.76 M(+48.2%) | $32.89 M(+6.8%) |
| Sep 2017 | - | $30.79 M(+14.4%) |
| Jun 2017 | - | $26.92 M(-0.9%) |
| Mar 2017 | - | $27.16 M(+38.4%) |
| Dec 2016 | $79.46 M(+9.4%) | $19.63 M(+10.3%) |
| Sep 2016 | - | $17.80 M(-19.9%) |
| Jun 2016 | - | $22.21 M(+12.1%) |
| Mar 2016 | - | $19.82 M(-9.3%) |
| Dec 2015 | $72.62 M(+38.5%) | $21.86 M(+16.0%) |
| Sep 2015 | - | $18.84 M(+13.1%) |
| Jun 2015 | - | $16.66 M(+9.3%) |
| Mar 2015 | - | $15.25 M(+9.5%) |
| Dec 2014 | $52.43 M(+35.0%) | $13.92 M(+0.2%) |
| Sep 2014 | - | $13.90 M(+7.2%) |
| Jun 2014 | - | $12.97 M(+11.4%) |
| Mar 2014 | - | $11.64 M(+26.0%) |
| Dec 2013 | $38.84 M(-11.5%) | $9.24 M(+9.7%) |
| Sep 2013 | - | $8.43 M(-26.2%) |
| Jun 2013 | - | $11.42 M(+17.1%) |
| Mar 2013 | - | $9.75 M(-47.3%) |
| Dec 2012 | $43.90 M(+55.2%) | $18.49 M |
| Dec 2011 | $28.29 M | - |
FAQ
- What is Revance Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Revance Therapeutics?
- What is Revance Therapeutics annual operating expenses year-on-year change?
- What is Revance Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Revance Therapeutics?
- What is Revance Therapeutics quarterly operating expenses year-on-year change?
What is Revance Therapeutics annual total operating expenses?
The current annual operating expenses of RVNC is $382.01 M
What is the all time high annual operating expenses for Revance Therapeutics?
Revance Therapeutics all-time high annual total operating expenses is $382.01 M
What is Revance Therapeutics annual operating expenses year-on-year change?
Over the past year, RVNC annual total operating expenses has changed by +$28.95 M (+8.20%)
What is Revance Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of RVNC is $74.50 M
What is the all time high quarterly operating expenses for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total operating expenses is $134.01 M
What is Revance Therapeutics quarterly operating expenses year-on-year change?
Over the past year, RVNC quarterly total operating expenses has changed by -$351.00 K (-0.47%)